administration condition of lnt for gastrointestinal cancer was designed as the following : lnt was administered intravenously at doses of 1 mg/person/day twice a week or 2 mg/person/day once a week in combination with mitomycine c + 5-fu ( mf ) or tegafur ( ft ) .
C0016360
fu
C0016778
tegafur